跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEMAZIN ULTRA COLD & FLU + COUGH DAY + NIGHT+ IMMUNE DEFENCE - TGA Drug Approval Details
Approvals
/
TGA
/
DEMAZIN ULTRA COLD & FLU + COUGH DAY + NIGHT+ IMMUNE DEFENCE
Approved
STANDARD
DEMAZIN ULTRA COLD & FLU + COUGH DAY + NIGHT+ IMMUNE DEFENCE
iNova Pharmaceuticals (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
25ed202eaf43d8b9
Company
iNova Pharmaceuticals (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
25ed202eaf43d8b9
Product Name
DEMAZIN ULTRA COLD & FLU + COUGH DAY + NIGHT+ IMMUNE DEFENCE
Artg Id
355164
Artg Name
DEMAZIN ULTRA COLD & FLU + COUGH DAY + NIGHT+ IMMUNE DEFENCE
Sponsor
iNova Pharmaceuticals (Australia) Pty Ltd
Company Detail Path
/organization/inova-pharmaceuticals-australia-pty-limited
Artg Date
2021-02-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
25ed202eaf43d8b9
Type
Standard
Back to TGA Approvals
